Article: Echo health - 'Cost is not the issue in cancer drug approval'

The issue of who gets new cancer drugs is becoming a political hot potato. Health Editor Barry Nelson met the head of the regional cancer network which, in the absence of national guidance, has to rule on whether your local primary care trust will pay for new drugsTHE director of a body which recommends which new cancer drugs will be available on the NHS in the region, has defended its role.Moira Davison, director of the North of England Cancer Drug Network - which includes a sub-group known as the NorthEast and Cumbria Cancer Drug Approvals Group - insists that the main criteria for approving cancer drugs are their effectiveness and their safety.While acknowledging the approvals group ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!